Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Douketis

Showing results (201-210 of 314) with videos related to

Pageof 32
Sort By:
Thrombosis Research|November 27, 2020
Weight-adjusted tinzaparin for venous thromboembolism prophylaxis in bariatric surgery patients weighing 160 kg or moreA Li, A Eshaghpour, E K Tseng, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|March 2, 2021
Rates of rebleeding, thrombosis and mortality associated with resumption of anticoagulant therapy after anticoagulant-related bleedingDerek H W Little, Rinku Sutradhar, Joshua O Cerasuolo, et al.
Blood Advances|August 7, 2020
Predictors of preprocedural direct oral anticoagulant levels in patients having an elective surgery or procedureJoseph R Shaw, Na Li, Thomas Vanassche, et al.
Journal of Thoracic Disease|February 17, 2017
Practice patterns in venous thromboembolism (VTE) prophylaxis in thoracic surgery: a comprehensive Canadian Delphi surveyJohn Agzarian, Lori-Ann Linkins, Laura Schneider, et al.
The Annals of Pharmacotherapy|May 26, 2005
Are brand-name and generic warfarin interchangeable? Multiple n-of-1 randomized, crossover trialsJennifer A Pereira, Anne M Holbrook, Lisa Dolovich, et al.
Journal of Thrombosis and Haemostasis : JTH|March 14, 2025
Perioperative management of direct oral anticoagulants in patients having a high-bleed-risk surgery or neuraxial procedure: the Perioperative Anticoagulant Use for Surgery Evaluation (PAUSE)-2 pilot randomized trialJames D Douketis, Na Li, Melanie St John, et al.
Journal of Thrombosis and Haemostasis : JTH|October 30, 2015
Effect of standardized perioperative dabigatran interruption on the residual anticoagulation effect at the time of surgery or procedureJ D Douketis, G Wang, N Chan, et al.
The Canadian Journal of Clinical Pharmacology = Journal Canadien De Pharmacologie Clinique|November 10, 2005
Are brand-name and generic warfarin interchangeable? A survey of Ontario patients and physiciansJennifer A Pereira, Anne M Holbrook, Lisa Dolovich, et al.
JAMA Internal Medicine|May 27, 2015
Bleeding, Recurrent Venous Thromboembolism, and Mortality Risks During Warfarin Interruption for Invasive ProceduresNathan P Clark, Daniel M Witt, Loren E Davies, et al.
Chest|July 14, 2009
Factors that predict risk of thrombosis in relatives of patients with unprovoked venous thromboembolismFrancis Couturaud, Christophe Leroyer, Jim A Julian, et al.
Pageof 32

Showing results (201-210 of 314) with videos related to

Sort By:
Pageof 32
Thrombosis Research|November 27, 2020
Weight-adjusted tinzaparin for venous thromboembolism prophylaxis in bariatric surgery patients weighing 160 kg or moreA Li, A Eshaghpour, E K Tseng, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|March 2, 2021
Rates of rebleeding, thrombosis and mortality associated with resumption of anticoagulant therapy after anticoagulant-related bleedingDerek H W Little, Rinku Sutradhar, Joshua O Cerasuolo, et al.
Blood Advances|August 7, 2020
Predictors of preprocedural direct oral anticoagulant levels in patients having an elective surgery or procedureJoseph R Shaw, Na Li, Thomas Vanassche, et al.
Journal of Thoracic Disease|February 17, 2017
Practice patterns in venous thromboembolism (VTE) prophylaxis in thoracic surgery: a comprehensive Canadian Delphi surveyJohn Agzarian, Lori-Ann Linkins, Laura Schneider, et al.
The Annals of Pharmacotherapy|May 26, 2005
Are brand-name and generic warfarin interchangeable? Multiple n-of-1 randomized, crossover trialsJennifer A Pereira, Anne M Holbrook, Lisa Dolovich, et al.
Journal of Thrombosis and Haemostasis : JTH|March 14, 2025
Perioperative management of direct oral anticoagulants in patients having a high-bleed-risk surgery or neuraxial procedure: the Perioperative Anticoagulant Use for Surgery Evaluation (PAUSE)-2 pilot randomized trialJames D Douketis, Na Li, Melanie St John, et al.
Journal of Thrombosis and Haemostasis : JTH|October 30, 2015
Effect of standardized perioperative dabigatran interruption on the residual anticoagulation effect at the time of surgery or procedureJ D Douketis, G Wang, N Chan, et al.
The Canadian Journal of Clinical Pharmacology = Journal Canadien De Pharmacologie Clinique|November 10, 2005
Are brand-name and generic warfarin interchangeable? A survey of Ontario patients and physiciansJennifer A Pereira, Anne M Holbrook, Lisa Dolovich, et al.
JAMA Internal Medicine|May 27, 2015
Bleeding, Recurrent Venous Thromboembolism, and Mortality Risks During Warfarin Interruption for Invasive ProceduresNathan P Clark, Daniel M Witt, Loren E Davies, et al.
Chest|July 14, 2009
Factors that predict risk of thrombosis in relatives of patients with unprovoked venous thromboembolismFrancis Couturaud, Christophe Leroyer, Jim A Julian, et al.
Pageof 32